or Try an Advanced Search...

    Technical Analysis for DNLI - Denali Therapeutics Inc.

    Grade Last Price % Change Price Change
    D 20.42 -0.46% -0.10
    DNLI closed up 1.33 percent on Friday, May 17, 2024, on 68 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    Earnings due: May 31
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical DNLI trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength -0.46%
    Multiple of Ten Bullish Other -0.46%
    Wide Bands Range Expansion -0.46%
    Overbought Stochastic Strength -0.46%
    Upper Bollinger Band Walk Strength 0.86%
    Inside Day Range Contraction 0.86%
    Wide Bands Range Expansion 0.86%
    Overbought Stochastic Strength 0.86%
    Upper Bollinger Band Touch Strength 0.86%
    Crossed Above 200 DMA Bullish -2.13%
    Older End-of-Day Signals for DNLI ...

       Recent Intraday Alerts

    Alert Time
    Down 1% 14 minutes ago
    Up 1% 21 minutes ago
    Upper Bollinger Band Resistance 3 days ago
    Up 2% 3 days ago
    Up 1% 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DNLI Chart by TradingView
    Basic chart:

    Profile

    Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence

    Is DNLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Denali Therapeutics: MPS Treatment Program Continues With End Of 2024 Data
    May 12 Cantor picks 14 undervalued biotech stocks worth a second look
    May 11 The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
    May 9 Denali Therapeutics First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.80 loss in 1Q 2023)
    May 8 Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
    May 7 Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
    May 7 Denali Therapeutics GAAP EPS of -$0.68 beats by $0.02
    May 7 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
    May 1 Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
    Apr 29 Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
    See more DNLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.31
    52 Week Low 14.56
    Average Volume 1,110,246
    200-Day Moving Average 19.91
    50-Day Moving Average 18.68
    20-Day Moving Average 17.49
    10-Day Moving Average 19.05
    Average True Range 0.99
    RSI (14) 64.91
    ADX 28.69
    +DI 36.83
    -DI 14.29
    Chandelier Exit (Long, 3 ATRs) 17.93
    Chandelier Exit (Short, 3 ATRs) 17.54
    Upper Bollinger Bands 21.22
    Lower Bollinger Band 13.75
    Percent B (%b) 0.91
    BandWidth 42.69
    MACD Line 0.64
    MACD Signal Line 0.13
    MACD Histogram 0.5171
    Fundamentals Value
    Market Cap 2.83 Billion
    Num Shares 138 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -21.82
    Price-to-Sales 7.32
    Price-to-Book 2.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 21.76
    Resistance 3 (R3) 21.71 21.25 21.55
    Resistance 2 (R2) 21.25 20.93 21.27 21.48
    Resistance 1 (R1) 20.88 20.73 21.06 20.93 21.41
    Pivot Point 20.41 20.41 20.50 20.44 20.41
    Support 1 (S1) 20.04 20.09 20.23 20.09 19.61
    Support 2 (S2) 19.58 19.90 19.60 19.54
    Support 3 (S3) 19.21 19.58 19.47
    Support 4 (S4) 19.26